{"id":"https://openalex.org/W2004457606","doi":"https://doi.org/10.1097/01.hjh.0000379075.79180.ee","title":"INTENSIVE TREATMENT WITH COMBINATION AMLODIPINE/VALSARTAN VS MODERATE THERAPY FOR HYPERTENSIVE PATIENTS WITH DIABETES OR CKD UNCONTROLLED ON ARB MONOTHERAPY: PP.17.149","display_name":"INTENSIVE TREATMENT WITH COMBINATION AMLODIPINE/VALSARTAN VS MODERATE THERAPY FOR HYPERTENSIVE PATIENTS WITH DIABETES OR CKD UNCONTROLLED ON ARB MONOTHERAPY: PP.17.149","publication_year":2010,"publication_date":"2010-06-01","ids":{"openalex":"https://openalex.org/W2004457606","doi":"https://doi.org/10.1097/01.hjh.0000379075.79180.ee","mag":"2004457606"},"language":"en","primary_location":{"id":"doi:10.1097/01.hjh.0000379075.79180.ee","doi":"https://doi.org/10.1097/01.hjh.0000379075.79180.ee","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.hjh.0000379075.79180.ee","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001968810","display_name":"James R. Sowers","orcid":"https://orcid.org/0000-0001-7938-7129","observed_orcids":["https://orcid.org/0000-0001-7938-7129"]},"institutions":[{"id":"https://openalex.org/I76835614","display_name":"University of Missouri","ror":"https://ror.org/02ymw8z06","country_code":"US","type":"education","lineage":["https://openalex.org/I76835614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J Sowers","raw_affiliation_strings":["University of Missouri School of Medicine, Columbia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Missouri School of Medicine, Columbia, USA","institution_ids":["https://openalex.org/I76835614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046628178","display_name":"Thomas D. Giles","orcid":"https://orcid.org/0000-0002-0476-7108","observed_orcids":["https://orcid.org/0000-0002-0476-7108"]},"institutions":[{"id":"https://openalex.org/I114832834","display_name":"Tulane University","ror":"https://ror.org/04vmvtb21","country_code":"US","type":"education","lineage":["https://openalex.org/I114832834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T Giles","raw_affiliation_strings":["Tulane University, New Orleans, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tulane University, New Orleans, USA","institution_ids":["https://openalex.org/I114832834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070274727","display_name":"Elizabeth Ofili","orcid":"https://orcid.org/0000-0003-4663-1767","observed_orcids":["https://orcid.org/0000-0003-4663-1767"]},"institutions":[{"id":"https://openalex.org/I6332465","display_name":"Morehouse School of Medicine","ror":"https://ror.org/01pbhra64","country_code":"US","type":"education","lineage":["https://openalex.org/I6332465"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E Ofili","raw_affiliation_strings":["Morehouse School of Medicine, Atlanta, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Morehouse School of Medicine, Atlanta, USA","institution_ids":["https://openalex.org/I6332465"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042843111","display_name":"Bertram Pitt","orcid":"https://orcid.org/0000-0001-5880-275X","observed_orcids":["https://orcid.org/0000-0001-5880-275X","https://orcid.org/0000-0001-7703-0345"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B Pitt","raw_affiliation_strings":["University of Michigan School of Medicine, Ann Arbor, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan School of Medicine, Ann Arbor, USA","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042910633","display_name":"Yodit Seifu","orcid":"https://orcid.org/0000-0002-9630-8215","observed_orcids":["https://orcid.org/0000-0002-9630-8215"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y Seifu","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112344083","display_name":"Rita Samuel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Samuel","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029510477","display_name":"Robert J. Hilkert","orcid":"https://orcid.org/0000-0001-6952-2649","observed_orcids":["https://orcid.org/0000-0001-6952-2649"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Hilkert","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002246155","display_name":"Suzanne Oparil","orcid":"https://orcid.org/0000-0002-7505-2599","observed_orcids":["https://orcid.org/0000-0002-7505-2599"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S Oparil","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, USA","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.12397311,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"28","issue":null,"first_page":"e295","last_page":"e295"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/combination-antihypertensive-therapy","display_name":"combination antihypertensive therapy","score":0.8939999938011169},{"id":"https://openalex.org/keywords/uncontrolled-hypertension","display_name":"uncontrolled hypertension","score":0.75},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.7059999704360962},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.9710000157356262},{"id":"https://openalex.org/keywords/stage-3-ckd","display_name":"CKD stage 3","score":0.9649999737739563},{"id":"https://openalex.org/keywords/blood-pressure-control","display_name":"blood pressure control","score":0.6710000038146973},{"id":"https://openalex.org/keywords/hydrochlorothiazide","display_name":"hydrochlorothiazide","score":0.828000009059906},{"id":"https://openalex.org/keywords/peripheral-edema","display_name":"peripheral edema","score":0.7620000243186951},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7799999713897705}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9749155640602112},{"id":"https://openalex.org/C2779646130","wikidata":"https://www.wikidata.org/wiki/Q411347","display_name":"Amlodipine","level":3,"score":0.776565670967102},{"id":"https://openalex.org/C2777387769","wikidata":"https://www.wikidata.org/wiki/Q155472","display_name":"Valsartan","level":3,"score":0.7080657482147217},{"id":"https://openalex.org/C2779766728","wikidata":"https://www.wikidata.org/wiki/Q421156","display_name":"Olmesartan","level":3,"score":0.6897082328796387},{"id":"https://openalex.org/C2780361556","wikidata":"https://www.wikidata.org/wiki/Q423930","display_name":"Hydrochlorothiazide","level":3,"score":0.6815589070320129},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5132677555084229},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4878990352153778},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.46097293496131897},{"id":"https://openalex.org/C2777482430","wikidata":"https://www.wikidata.org/wiki/Q7168709","display_name":"Peripheral edema","level":3,"score":0.43082329630851746},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.24862593412399292},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.19384047389030457},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.1645086109638214}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/01.hjh.0000379075.79180.ee","doi":"https://doi.org/10.1097/01.hjh.0000379075.79180.ee","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.hjh.0000379075.79180.ee","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.4300000071525574}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2412535067","https://openalex.org/W2368002165","https://openalex.org/W2376706830","https://openalex.org/W2089173861","https://openalex.org/W2320446673","https://openalex.org/W2053932973","https://openalex.org/W2332588052","https://openalex.org/W1988458482","https://openalex.org/W2062917742","https://openalex.org/W2182829519"],"abstract_inverted_index":{"Objective:":[0],"Hypertensive":[1],"patients":[2],"(pts)":[3],"with":[4,35,112,123,163,231],"diabetes":[5],"(D)":[6],"or":[7,101,115,135,226],"CKD":[8,63,73,194,229],"are":[9],"at":[10,146,158,167],"high":[11],"risk":[12],"and":[13,71,122,149,191,217],"require":[14],">":[15,66,76,84,94],"=":[16,67,77,85,95,127],"2":[17,148,193,228],"agents":[18,106],"for":[19,93,119],"BP":[20,48,181],"control.":[21],"In":[22],"a":[23],"12-wk":[24],"study":[25],"of":[26,38,151,223,235],"hypertensive":[27,224],"pts":[28,64,74,100,102,195,230],"unresponsive":[29],"to":[30,42,132,139,155],"ARB":[31,89,110],"monotherapy,":[32],"initial":[33],"treatment":[34,178,185,222],"intensive":[36,144,233],"dose":[37,52,234],"amlodipine/valsartan":[39],"(A/V":[40],"5/320":[41,134],"10/320":[43,140],"mg)":[44],"provided":[45,179,237],"significantly":[46],"greater":[47,238],"efficacy":[49,240],"than":[50,91,108,241],"moderate":[51,184,242],"(5/160":[53],"mg).":[54],"Here":[55],"we":[56],"present":[57],"data":[58],"in":[59,142,189,202],"D":[60,190],"pts,":[61],"stage-2":[62],"(eGFR":[65,75],"60\u2013<90":[68],"mL/min/1.73":[69,79],"m2),":[70],"stage-3":[72],"30\u2013<60":[78],"m2).":[80],"Methods:":[81],"Pts":[82],"aged":[83],"18":[86],"years":[87],"on":[88,105],"(other":[90],"V)":[92],"28":[96,120],"d":[97],"(with":[98],"treatment-na\u00efve":[99],"not":[103],"controlled":[104],"other":[107],"an":[109,232],"treated":[111],"olmesartan":[113],"20":[114],"40":[116],"mg,":[117],"respectively,":[118],"d)":[121],"uncontrolled":[124],"MSSBP":[125,173],"(>":[126],"150\u2013<200":[128],"mmHg)":[129],"were":[130,200,212],"randomized":[131],"A/V":[133,236],"5/160":[136],"mg;":[137],"increased":[138],"mg":[141,154,166],"the":[143],"arm":[145],"Wk":[147,159,168,187],"addition":[150],"HCTZ":[152,164],"12.5":[153,165],"both":[156,203],"arms":[157],"4;":[160],"optional":[161],"up-titration":[162],"8":[169],"was":[170],"allowed":[171],"if":[172],">140":[174],"mmHg.":[175],"Results:":[176],"Intensive":[177],"significant":[180],"reductions":[182],"vs":[183],"by":[186],"4":[188],"stage":[192,227],"(table).":[196],"Overall,":[197],"percent":[198],"AEs":[199,211],"similar":[201],"groups":[204],"(36.3%":[205],"intensive,":[206],"37.6%":[207],"moderate);":[208],"most":[209],"common":[210],"peripheral":[213],"edema":[214],"(8.7%,":[215],"4.5%)":[216],"dizziness":[218],"(5.1%,":[219],"3.9%).Conclusion:":[220],"Initiating":[221],"diabetic":[225],"antihypertensive":[239],"treatment.":[243]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2025-10-10T00:00:00"}